Evidence map›Paper›PMID 31219596›Full record

ArticleSchizophrenia bulletin2020

Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia.

Christoffer Polcwiartek, Kristian Kragholm, Steen M Hansen, Brett D Atwater, Daniel J Friedman, Carlo A Barcella, Claus Graff, Jonas B Nielsen, Adrian Pietersen, Jimmi Nielsen and 3 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Coronary Artery Disease in Patients with Severe Mental Illness.Interventional cardiology (London, England) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Impairment of the cardiac ejection fraction by blocking dopamine D2 receptors induced by long-acting injectable antipsychotic treatment.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christoffer PolcwiartekDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Kristian KragholmDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Steen M HansenUnit of Epidemiology and Biostatistics, Aalborg University Hospital, Aalborg, Denmark.
Brett D AtwaterDivision of Cardiology, Duke University Medical Center, Durham, NC.
Daniel J FriedmanDivision of Cardiology, Duke University Medical Center, Durham, NC.
Carlo A BarcellaDepartment of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Copenhagen, Denmark.
Claus GraffDepartment of Health Science and Technology, Aalborg University, Aalborg, Denmark.
Jonas B NielsenLaboratory for Molecular Cardiology, Department of Cardiology, Copenhagen University Hospital, Copenhagen, Denmark.
Adrian PietersenCopenhagen General Practitioners' Laboratory, Copenhagen, Denmark.
Jimmi NielsenMental Health Center Glostrup, Copenhagen University Hospital Glostrup, Copenhagen, Denmark.
Peter SøgaardDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Christian Torp-PedersenDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Svend E JensenDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are limited data on electrocardiogram (ECG) characteristics and their association with psychotropic drugs in schizophrenia.

methodsUsing a cross-sectional design, we included Danish primary care patients with first-time digital ECGs from 2001 to 2015. Patients diagnosed with schizophrenia before ECG recording were matched 1:5 on age, sex, and ECG recording year to controls without psychiatric disease. Multivariable logistic regression was used to compute odds ratios (ORs) with 95% confidence intervals (CIs).

resultsWe included 4486 patients with schizophrenia matched with 22 430 controls (median age, 47 years; male, 55%). Between groups, the prevalence of abnormal ECGs was similar (54%, P = .536), but patients with schizophrenia demonstrated higher median heart rate (79 vs 69 beats per minute, P < .001) and Fridericia-corrected QT (QTc) interval (416 vs 412 ms, P < .001) than controls. QTc prolongation was also more prevalent among patients with schizophrenia (3.4% vs 1.1%, P < .001), and so were pathological Q waves (5.3% vs 3.9%, P < .001). Patients with schizophrenia less frequently demonstrated left ventricular hypertrophy (6.1% vs 9.6%, P < .001) and atrial fibrillation or flutter (0.7% vs 1.4%, P < .001). Among patients with schizophrenia only, particularly antipsychotics were associated with abnormal ECGs (OR, 1.20; 95% CI, 1.04-1.39).

conclusionsPatients with schizophrenia demonstrate a different cardiovascular risk profile than matched controls without psychiatric disease, with higher prevalence of elevated heart rate, QTc prolongation, and pathological Q waves, and lower prevalence of left ventricular hypertrophy and atrial fibrillation or flutter. Particularly antipsychotics were associated with abnormal ECGs. This underscores an integrated care approach when ECG abnormalities are detected in this group.

Indexed as

AdultAntipsychotic AgentsCross-Sectional StudiesDenmarkElectrocardiographyFemaleHeart DiseasesHeart RateHumansLong QT SyndromeMaleMiddle AgedPolypharmacySchizophreniaAntipsychotic Agentsantipsychoticscardiovascular diseaseelectrocardiogrampolypharmacyQT prolongationschizophrenia

Identifiers

PMID31219596
PMCPMC7442389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.